The Research Operations Manager will be responsible for the staffing operations of the IHTC Research Department. The Research Operations Manager will work closely with the IHTC Medical Director, the Director of Compliance and Community Programs, the Research Administrative Manager, and the Director of Quality Assurance in Clinical Research to ensure optimal efficiency, staffing, and resources for an effective research department.
The IHTC offers an extremely attractive compensation and benefits package. Employees can anticipate an annual cash incentive opportunity—in addition to base pay—as well as a generous retirement benefit.
Supervise, mentor, train and support research staff
Planning and executing clinical research studies
Coordinate logistics of and lead weekly Research meetings and Research Coordinator meetings
Editing and proofing consents and other IRB and regulatory documentation
Monitor submission of all necessary IRB forms and study documentations submitted to the IRB
Review and ensure consistent, complete and timely documentation of IP infusions in clinic
Review Serious Adverse Event (SAE) reporting and oversee appropriate follow-up actions as appropriate
Monitor inpatient sign-out to ensure timing and accurate reporting of study subject hospitalizations/SAEs
Review physical exams notes and other study documentation to ensure consistency
Assessing quality of clinical research monitors
Occasional travel to professional research meetings and IHTC outreach clinics
Bachelor’s Degree in science related field is required
Certification in Clinical Research is preferred
Minimum 2 years of clinical research coordinator experience is required
Minimum 5 years of supervision experience is required
Minimum 2 years of training experience is strongly preferred
Valid driver’s license and automobile insurance for work related travel
About Indiana Hemophilia and Thrombosis Center
The Indiana Hemophilia and Thrombosis Center (IHTC) was founded in 1998 by two internationally recognized experts, Drs. Amy Shapiro and Anne Greist.
As IHTC expanded, it became one of the nation’s largest hemophilia treatment centers—and, as experts in the care of bleeding disorders, the only center in Indiana to receive federal designation. Now, IHTC delivers patient- and family-centered, comprehensive care for hemophilia, thrombosis, von Willebrand disease, sickle cell disease, and other bleeding and clotting disorders—including rare conditions.
IHTC began with a vision for a center where patients and families affected by blood disorders could receive the best treatment. With extensive experience in hematologic disorders and depth of specialization in the field, our doctors, nurses, and specialists are focused on improving quality of life for our blood disorder patients and their families.
The Indiana Hemophilia & Thrombosis Center (IHTC) is committed to providing the highest quality comprehensive services and holistic care to patients with bleeding, clotting, and other hematologic disorders, and to their families.
A future where... people with rare blood disorders flourish
Our Research Department:
Clinical research can improve overall understanding of bleeding and clotting disorders, increase knowledge of genetics, and provide ongoing safety information of therapy. Clinical research studies may offer patients and payors substantial new treatment options and cost savings related to laboratory testing.
The IHTC has a long-standing history of leadership in clinical research, with numerous active studies available to eligible patients. The IHTC performed the world’s first human infusion of the following products:
Genetically engineered factor IX concentrate
Long-acting genetically engineered immunoglobulin fused factor IX concentrate
Genetically engineered von Willebrand factor concentrate
Genetically engineered bio-similar factor IX concentrate
Intravenous Plasminogen (Human) Concentrate
The IHTC independently evaluates the need for each study, weighing above all the project’s safety as well as the potential impact on future patient care. The IHTC coordinates a wide range of clinical research including pharmaceutical, observational, investigator-initiated, quality-of-life analyses, and nationally funded studies (e.g. Centers for Disease Control and Prevention and National Institute of Health).